Max Healthcare approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026 with unmodified auditor opinion.
Board recommended final dividend of ₹2 per share (20% of face value) for FY 2025-26, subject to shareholder approval.
Approved construction of Phase-I of Max Super Specialty Hospital in Lucknow with ~712 bed capacity at estimated cost of ~₹1,400 Cr.
Board approved re-appointment of cost auditors and director, and shifting of registered office from Maharashtra to Haryana.